Respirent Pharmaceuticals Co Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Chongqing China (2016)

Organization Overview

First Clinical Trial
2018
NCT03676413
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Respirent Pharmaceuticals Co Ltd.